Brief: Royal Bank Of Canada's Long Position In H-Shares Of Haohai Biological Falls To 4.58% - HKEX Filing
Oct 19 (Reuters) - Hong Kong stock exchange filing:
* ROYAL BANK OF CANADA'S LONG POSITION IN H-SHARES OF
SHANGHAI
HAOHAI BIOLOGICAL TECHNOLOGY 6826.HK REDUCED TO 4.58% ON OCT
13 FROM 5.11% - HKEX FILING
Source text
Further company coverage: 6826.HK
(Reporting by Hong Kong newsroom)
((twinnie.siu@tr.com; 852-3462 7715;))
Recent news on Shanghai Haohai Biological Technology
See all newsChina's Haohai Biological H1 revenue falls, partly hurt by end of Brighten Optix distribution
Brief: Shanghai Haohai Biological Technology Says Resignation Of Hou Yongtai As Exec Director, Chair
Brief: Shanghai Haohai Biological Technology Updates On Investigation Of Jiang Wei's Suspected Insider Trading Case
Brief: Shanghai Haohai Biological Technology Proposes To Elect Tian Min As An Additional Executive Director
Brief: Shanghai Haohai Biological Technology Posts Qtrly Net profit Attributable Of RMB73.6 Mln.